Ocugen, Inc

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. 

CEO
Shankar Musunuri
CEOShankar Musunuri
Employees
56
Employees56
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2013
Founded2013
Employees
56
Employees56

OCGN Key Statistics

Market cap
404.98M
Market cap404.98M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
5.85M
Average volume5.85M
High today
$1.88
High today$1.88
Low today
$1.79
Low today$1.79
Open price
$1.81
Open price$1.81
Volume
5.13M
Volume5.13M
52 Week high
$17.65
52 Week high$17.65
52 Week low
$1.67
52 Week low$1.67

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

OCGN Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.